CCL19 reduces tumour burden in a model of advanced lung cancer

Epstein–Barr virus-induced molecule 1 ligand chemokine (CCL19) is a CC chemokine that chemoattracts both dendritic cells (DC) and T lymphocytes. We evaluated the antitumour efficacy of CCL19 in a murine model of spontaneous bronchoalveolar cell carcinoma. These transgenic mice (CC-10 TAg) express th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillinger, S, Yang, S-C, Batra, R K, Strieter, R M, Weder, W, Dubinett, S M, Sharma, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361223/
https://www.ncbi.nlm.nih.gov/pubmed/16598185
http://dx.doi.org/10.1038/sj.bjc.6603061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361223/
https://www.ncbi.nlm.nih.gov/pubmed/16598185
http://dx.doi.org/10.1038/sj.bjc.6603061

Ejemplares similares